Market Overview

UPDATE: Jefferies Assumes Coverage on Life Technologies, Downgrades to Hold Following Recent Takeout Bid

Share:
Related LIFE
aTyr Pharma Initiates Phase 1b/2 Clinical Trial for Patients with Limb Girdle Muscular Dystrophy 2B
aTyr Pharma Announces Change in Leadership

In a report published Monday, Jefferies analyst Brandon Couillard assumed coverage on Life Technologies Corp. (NASDAQ: LIFE), downgraded the rating from Buy to Hold, but raised the price target from $58.00 to $76.00.

In the report, Couillard noted, “We are assuming coverage of LIFE, and lowering our investment rating to Hold (from Buy) following TMO's recent takeout bid. We do not expect material regulatory issues to surface, given modest direct overlap between the two businesses and view a competitive bid as unlikely. Our price target moves to $76 (from $58), in line with TMO's offer.”

Life Technologies Corp. closed on Monday at $73.54.

Latest Ratings for LIFE

DateFirmActionFromTo
Dec 2015CitigroupInitiates Coverage onNeutral
Jun 2015JP MorganInitiates Coverage onOverweight
Aug 2013BairdDowngradesOutperformNeutral

View More Analyst Ratings for LIFE
View the Latest Analyst Ratings

Posted-In: JefferiesAnalyst Color Downgrades Analyst Ratings

 

Related Articles (LIFE)

Get Benzinga's Newsletters